Law Firm Announces Class Action Against The Medicines Company

Law Firm Announces Class Action Against The Medicines Company 2

 

NEW YORK, March 4, 2014 LawFuel.com — The Rosen Law Firm, P.A. announces that a class action lawsuit has been filed on behalf of purchasers of the securities of The Medicines Company (Nasdaq:MDCO) between February 20, 2013 and February 12. 2014, inclusive (the “Class Period”) seeking remedies under the federal securities laws.

To join The Medicines Company class action, visit the firm’s website at http://rosenlegal.com, or call Phillip Kim or Kevin Chan toll-free at 866-767-3653; you may also email [email protected] or [email protected] for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.

The lawsuit alleges that during the Class Period, the Company and certain of its executive officers misrepresented or failed to disclose that: (a) the Company’s Cangrelor drug candidate, did not show superiority over a competing drug already approved by the FDA; and (b) the clinical trials which compared Cangrelor to a competing drug were unethically and inappropriately administered.

On February 10, 2014, the (“FDA”) issued a report indicating that Cangrelor was not shown to be as good or superior to a rival drug and a new trial should be conducted before the drug is considered for approval. The report also states that the related trials “were conducted unethically” and Cangrelor should not be approved “on that fact alone.”

If you wish to serve as lead plaintiff, you must move the Court no later than April 22, 2014.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at [email protected] or [email protected] You may also visit the firm’s website at http://rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.


    <!–li>

Digg

Digg

  •  

Scroll to Top